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Prevalence of intestinal complications in
inﬂammatory bowel disease: a comparison between
paediatric-onset and adult-onset patients
Denise Herzoga, Nicolas Fournierb, Patrick Buehrd, Vanessa Ruegerd, Rebekka Kollerd, Klaas Heylandd,
Andreas Nydeggerc and Christian P. Braeggerd,e; on behalf of the Swiss IBD Cohort Study Group
Introduction Intestinal complications in inﬂammatory bowel disease indicate active inﬂammation and typically result in the
intensiﬁcation of therapy.
Aim To analyse whether the rates of intestinal complications were associated with age at disease onset.
Patients and methods Data from 1506 individuals with Crohn’s disease (CD) and 1201 individuals with ulcerative colitis (UC)
were obtained from the Swiss inﬂammatory bowel disease cohort study database, classiﬁed into groups on the basis of age at
diagnosis (<10, <17, < 40 and >40 years of age), and retrospectively analysed.
Results In CD patients, the rates of stricturing (29.1–36.2%), abdominal penetrating disease (11.9–18.2%), resectional surgery
(17.9–29.8%) and perianal disease (14.7–34.0%) were correlated with disease duration, but not age at diagnosis. However, paediatric-
onset CD was associated with higher rates of multiple, rectal and anal strictures and earlier colon surgery. In addition, perianal disease
occurred earlier, required earlier surgical intervention, and was more often combined with stricturing and penetrating disease. Finally,
anal ﬁssures were more prevalent among younger patients. In UC patients, the rates of progression or extension of disease (0–25.8%)
and colectomy (3.0–8.7%) were dependent on disease duration, but not age at disease onset. Paediatric-onset disease was
associated with a higher rate of extensive colitis at diagnosis and earlier progression or extension of disease, and nonsurgically treated
patients with the youngest ages at onset more frequently required antitumour necrosis factor-α treatments.
Conclusion The higher rates of intestinal complications, including those of the small and large bowel and in the anal region, in
paediatric-onset CD patients point towards a level of inﬂammation that is more difﬁcult to control. Similar ﬁndings were also evident in
UC patients. Eur J Gastroenterol Hepatol 29:926–931
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Intestinal complications developing during the course of
inﬂammatory bowel disease (IBD) indicate active inﬂam-
mation and disease progression or extension, typically
resulting in the intensiﬁcation of medical therapy or in s
urgical intervention. Intestinal complications, including
stricture, abscess and ﬁstula development, are present in
38% of patients within the ﬁrst 10 years of paediatric-onset
Crohn’s disease (CD) [1] and in 31.6% of patients with
adult-onset CD [2]. Previous studies have also shown that
patients with CD diagnosed before the age of 40 years have
more disabling disease outcomes [3] and that disease pro-
gression or extension is more rapid in childhood-onset IBD
[4]. Data suggest that within 10 years after being diagnosed
with ulcerative colitis (UC), 14% of adult-onset patients will
have experienced progression or extension of disease [5],
whereas 50% of paediatric-onset patients will experience a
similar outcome [6,7]. In contrast, the colectomy rate has
been reported to be similar in both age groups, namely, 20%
in patients with paediatric onset after the age of 5 years
[6–8] and 8.7–28% in adult-onset patients with UC [5].
Little is known about the prevalence of intestinal
complications in paediatric or adult patients in Switzerland
after stratiﬁcation by age at disease onset. In 2006, the
Swiss Inﬂammatory Bowel Disease Cohort Study (SIBDCS),
a nationwide cohort study on patients with IBD, was initi-
ated [9]. The aim of the present study was to assess the
prevalence of intestinal complications in this study cohort
and stratify patients according to age at disease onset. We
hypothesized that disease onset during childhood would be
a risk factor for a higher complication rate.
Patients and methods
As of March 2014, 2972 patients diagnosed with CD, UC or
inﬂammatory bowel disease-unclassiﬁed (IBD-U) according to
standard criteria [9] were registered in the SIBDCS database.
The study protocol for this cohort study was approved by the
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central and local ethics committees in Switzerland in 2006.
Patient recruitment was performed at the following six
university centres in western and eastern Switzerland, Geneva,
Lausanne, Bern, Basel, Zurich and St Gallen, as well in
selected regional centres, with the University of Lausanne
serving as the coordinating centre and housing the database
[10]. Retrospective data since diagnosis were obtained from
patient charts, and clinical data were collected during medical
visits at inclusion and follow-up by the patient’s gastro-
enterologist or a specialized study nurse who completed
clinical report forms. The forms were then sent to the data
centre for validation and data entry. The following data were
obtained from this database: date of birth, sex, family history
of IBD (ﬁrst degree relatives), age at IBD diagnosis and at
inclusion, type of IBD (CD, UC, IBD-U), disease location
(recorded according to Montreal classiﬁcation) [11] on the
basis of the endoscopies, radiological assesements or surgical
interventions, and comprehensive histological results (epithe-
lioid granulomas, chronic architectural changes or mucosal
secretion depletion). Furthermore, data on the occurrence of
strictures (duodenojejunal, ileal, ileocaecal valve, colon,
rectum and anus, and anastomosis, as diagnosed by endo-
scopic, radiologic or surgical means), abdominal penetrating
disease (enteroenteral, enterovesical, enterocutaneous ﬁstulas
and perforation and intra-abdominal abscesses as diagnosed
by radiologic or surgical means), perianal disease (PD) (high
and low perianal, perineal, vaginal ﬁstulas, chronic or acute
anal ﬁssures and perianal abscesses as diagnosed by clinical,
radiologic or surgical examination) in CD and progression or
extension of disease and ileal involvement in UC were
retrieved. In addition, data on the necessity of treatments that
were considered to indicate disease progression, such as the
need for tumour necrosis factor-α inhibitors (anti-TNF-α),
independent of success, failure or cessation for adverse effects,
and the necessity for abdominal resectional surgery [small
bowel, ileocaecal or any type of colonic resection (right, left,
sigmoid resection, subtotal colectomy or total proctoco-
lectomy)] or perianal surgery (abscess drainage, ﬁstulectomy,
seton placement, ﬁbrin/glue instillation and mucosal sliding
ﬂap) were obtained. The outcome was deﬁned as the presence
of stricturing, penetrating or PD in CD, progression or
extension of disease or backwash ileitis in UC, or need for
therapies such as surgery or anti-TNF-α therapy. The patients
were grouped according to the Paris classiﬁcation [12] into
categories on the basis of age at diagnosis (<10,<17
and<or>40 years). The outcome variables were dichot-
omized into present or absent.
Statistics
The distribution of continuous data was assessed using
Normal-QQ-plots. Gaussian distributed data are presented
as the mean±SD and range, and non-Gaussian distributed
data are presented as the median and interquartile range.
Differences in the distribution of continuous data between
the two groups were assessed using Student’s t-test for
Gaussian data or the Wilcoxon–Mann–Whitney rank sum
test for non-Gaussian data. Differences in continuous data
distribution between more than two groups were assessed
using Fisher’s F-test for Gaussian data or the Kruskal–Wallis
test for non-Gaussian data. Categorical data are presented as
raw counts and relative percentages. Differences in the dis-
tribution of categorical data between the groups were
assessed using the χ2-test or Fisher’s exact test in cases of
insufﬁcient sample size. Bonferroni’s correction was used for
multiple testing. Kaplan–Meier estimates were used to assess
the complication-free survival time during SIBDCS follow-up
and the log-rank test was used to assess differences between
survival curves. Multivariate Cox proportional hazard
regression was used to estimate the rates of complication-free
survival in association with variables with unknown intervals
between disease onset and the occurrence of the complication
before study inclusion. Logistic regression was used to assess
associations between complications and age categories after
adjustment for disease duration. For the purpose of the
present study, a P-value of less than 0.05 was considered
statistically signiﬁcant. Statistical analyses were carried out
using SPSS statistics 23.0 (IBM, Armonk, New York, USA).
Results
After the exclusion of 76 patients with IBD-U, 155 patients
with CD and 34 patients with UC because of incomplete
data, data for 1506 (718 male, 888 female patients)
patients with CD and 1201 (642 male, 559 female
patients) patients with UC were analysed.
Patients with Crohn’s disease
For a description of the baseline characteristics, see
Table 1. Only a few patients had an additional assessment
of the upper gastrointestinal tract performed after diag-
nosis with CD (13/47 patients the<10 years age class,
42/182 patients in the< 17 age class, 125/1000 patients in
the< 40 age class and 41/277 patients in the >40 years age
class); thus, this location of initial assessment was not
included with the analysis. No sex difference was identiﬁed
between age groups; therefore, we analysed male and
female patients together.
The comparisons of the rate of intestinal complications
between age groups yielded the following results:
The overall prevalence of strictures was the same in all
age groups, but when looking at speciﬁc stricture types, the
rate of rectal and anal strictures was higher in patients with
the youngest age at onset. Furthermore, multiple strictures
were more frequent in paediatric-onset patients (Table 1).
The results of the survival analysis by age group showed no
difference in the intervals between disease onset and the
occurrence of colonic (log-rank P=0.17) or small bowel
strictures (log-rank P=0.29). Looking at the adult-onset
cohort separately, strictures overall (Pearson’s χ2=45.4,
P<0.001) and small bowel (Pearson’s χ2=85.6, P<0.001)
or colonic strictures (Pearson’s χ2=10.1, P=0.04) speciﬁ-
cally were correlated with the initial location and with the
presence of granulomas (Pearson’s χ2=19.6, P<0.001) at
diagnostic biopsy. In contrast, in the paediatric-onset group,
no such correlation was found.
Overall, abdominal penetrating disease occurred at a
similar rate in patients of all age categories (Table 1), and the
rates were also similar when ﬁstula types were analysed
individually (enteroenteral: 28.6–45.5%, P=0.9; enter-
ovesical: 12.1–28.6% P=0.7; enterocutaneous: 25.8–33.3%
P=0.8). The duration from CD diagnosis to the manifesta-
tion of penetrating disease was similar in all age classes
(log-rank P=0.4). Only the rate of intra-abdominal absces-
ses was correlated with younger age at disease onset
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(Pearson’s χ2=12.5, P=0.006). In the adult-onset group
alone, no correlations between the rate of penetrating disease
and initial location or the presence of granuloma at diagnosis
were identiﬁed. In the paediatric cohort, only the presence of
granulomas at initial biopsy was correlated with the rate of
penetrating disease (Pearson’s χ2=11.2, P=0.004).
The rate of resectional surgery for stricturing or pene-
trating disease was the lowest in patients with disease onset
less than 17 years. The survival analysis by age group
showed that colonic resectional surgery occurred signiﬁcantly
earlier in patients with disease onset before the age of
10 years (log-rank P=0.048), whereas the intervals between
disease onset and small bowel (log-rank P=0.5) and ileo-
caecal resectional surgery (log-rank P=0.132) were similar
in all age groups.
The overall rate of perianal ﬁstulizing disease (PD)
(Table 2) and the rates of individual ﬁstula types [low
(32.8–34.8%, P=0.7), high (3.5–8.7%, P=0.6), perineal
(11.5–22.5% P=0.2) or vaginal ﬁstula (4.3–12.9%, P=0.5)]
were similar in all age groups. The rate of ﬁstulizing PD was
correlated with the rate of stricturing disease (Pearson’s
χ2=7.9, P=0.005), but not with that of penetrating disease,
initial location or granulomas in the paediatric cohort. In
contrast, in adult-onset patients, the rate of ﬁstulizing PD was
correlated with stricturing (Pearson’s χ2=11.6, P=0.001),
penetrating disease (Pearson’s χ2=22.5, P<0.001), initial
disease location (Pearson’s χ2=30.0, P<0.001) and granu-
loma at initial biopsy (Pearson’s χ2=9.7, P=0.01). Anal
ﬁssures were signiﬁcantly more prevalent in the patients with
the youngest age at onset, but no correlation was identiﬁed
between anal ﬁssures and any of the other variables tested. In
adult-onset patients, anal ﬁssures were correlated with colonic
initial disease location (Pearson’s χ2=12.8, P=0.01).
The rates of the assessed treatments (anti-TNF-α anti-
bodies or surgical intervention) were similar in paediatric
and adult disease onset CD. The results of the survival
analysis, however, showed that PD (log-rank P=0.022)
and perianal surgery (log-rank 0.006) occurred signiﬁcantly
earlier in paediatric-onset than adult-onset CD patients.
The results of the multivariate Cox proportional hazard
regression did not show any associations between age at
disease onset and the development of colonic or small bowel
stricturing disease, abdominal penetrating disease or PD
(Table 3) or the requirement of surgical intervention. Only
having required anti-TNF-α therapy was identiﬁed as a risk
factor for penetrating disease and surgery of the colon
[relative risk (RR): 1.2; 95% conﬁdence interval (CI):
1.04–1.37; P=0.02], small bowel (RR: 1.2; 95% CI
1.01–1.40; P=0.04) or perianal region (RR: 1.2%; 95
CI: 1.03–1.38; P=0.02), independent of the age at
diagnosis of CD.
Patients with ulcerative colitis
For a description of the baseline characteristics, see
Table 4. The sex distributions between age groups and the
variables tested were similar; therefore, male and female
patients were analysed together. The comparisons of the
rate of complications between age groups yielded the fol-
lowing picture:
Progression or extension of disease (Table 4) occurred
at a similar rate in all age classes, but the results of the
survival analysis showed that this complication occurred
Table 1. Characteristics and disease behaviour of patients with Crohn’s disease
Age category [n (%)] (years)
<10 (n=47) <17 (n=182) <40 (n=1000) >40 (n=277) Pa
Sex (male) (%) 29 (61.7) 101 (55.5) 452 (45.2) 136 (49.0) NS
Age at diagnosis [median (IQR)] (months) 90 (61) 163.5 (34) 295.0 (121) 619 (175)
Positive family history 12 (25.5) 29 (15.9) 134 (13.4) 32 (11.5) 0.5
NA 2 (4.3) 14 (7.7) 73 (7.3) 21 (7.5)
Initial location
L1 6 (12.8) 22 (12.1)* 248 (24.8)* 89 (32.1)* <0.001*
L2 11 (23.4) 28 (15.4)* 216 (21.6) 83 (30.0)* 0.01*
L3 29 (61.7)& 128 (70.3)* 233 (23.4)*,& 37 (13.4)*,& 0.001*,&
L4 1 (2.1) 4 (2.2) 8 (0.8) 3 (1.1)
Histology at diagnostic biopsy
Granuloma 23 (50.0)* 64 (35.6)& 233 (23.4)*,& 37 (13.4)*,& 0.006*,&
NA 2 (4.3) 22 (12.2) 155 (15.6) 47 (17.0)
Disease duration up to last FU [median (IQR)] (months) 82.5 (143) 67.5 (149)* 133.0 (171)* 88.0 (107) 0.02*
All strictures (SD) 17 (36.2) 53 (29.1) 391 (39.2) 93 (33.3) NS
Multiple strictures, excluding anastomotic 5 (29.4)* 10 (18.9)& 28 (7.2)*,& 5 (5.4)* 0.02*,&
Duodenojejunal 3 (17.7)* 4 (7.6) 13 (3.3)* 3 (3.2) 0.02*
Ileal 10 (58.8) 32 (60.4) 240 (61.4) 66 (71.0) 0.3
Colonic 4 (23.5) 14 (26.4) 85 (21.7) 15 (16.1) 0.4
Rectal 3 (17.7) 0 16 (4.1)* 1 (1.1)* 0.01*
Anal 3 (17.7)* 4 (7.5) 18 (4.6) 1 (1.1)* 0.01*
Total PND 7 (14.9) 33 (18.1) 182 (18.2) 33 (11.9) NS
Enteroenteral, enterovesical, enterocutaneous 6 (85.7) 27 (81.8) 146 (87.9) 30 (90.9) NS
Intra-abdominal abscess 2 (28.6) 17 (51.5) 88 (48.4) 8 (24.2) NS
Total PND and SD 7 (14.9) 19 (10.4) 115 (11.5) 18 (6.5) NS
Total resectional surgery, single or multiple 14 (29.8) 26 (14.3) 230 (23.0) 50 (17.9) NS
Resectional surgery and anti-TNF-α 8 (57.1) 9(34.6) 84 (36.5) 16 (32.0) NS
Anti-TNF-α, no surgical intervention 13 (27.7) 43 (23.6) 290 (29.0) 61 (22.0) NS
L1, ileal; L2, colonic; L3, Ileocolonic.; L4, upper gastrointestinal tract.
FU, follow-up; IQR, interquartile range; PND, abdominal penetrating disease; SD, stricturing disease; TNF-α, tumour necrosis factor-α.
aBonferroni corrected differences.
*variables with signiﬁcant difference.
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earlier in paediatric-onset patients (log-rank P= 0.03). In
the adult cohort, disease progression was correlated with
ileal involvement (Pearson’s χ2=140.4, P<0.001), but not
with mucosal secretion depletion or chronic architectural
changes at initial biopsy or the need for colonic resection.
In the paediatric-onset cohort, progression or extension of
disease was not correlated with any variables. Backwash
ileitis occurred at a similar rate in all age groups, but later
(log-rank P=0.002 for age group <10 years) in the
youngest-onset group. The rate of colectomy did not differ
between age groups and occurred within the same interval
from diagnosis in all age groups (log-rank P= 0.678). The
rate of treatments with anti-TNF-α antibodies was higher
in paediatric-onset patients without colectomy (Table 4).
The results of the multivariate Cox proportional hazard
regression showed that age at diagnosis was not a risk
factor for any of the assessed complications; that left-sided
colitis, independent of age at diagnosis, was associated
with disease extension; and that age older than 40 years
was associated with backwash ileitis and anti-TNF-α
treatments (Table 5).
Discussion
The investigation of whether the rates and types of
intestinal complications were dependent on the age at
disease onset yielded the following results: at baseline, our
CD age groups [12] differed signiﬁcantly in terms of initial
disease location, histological markers at diagnostic biopsy
and disease duration, differences that have been reported
previously by other studies [4,13–18]. Thus, we compared
unequal groups for the development of intestinal compli-
cations. Despite these differences, the overall prevalence
rates of strictures (29–39%) and of penetrating abdominal
disease (11.9–18.2%) were similar in all age groups and
dependent on disease duration, but not age at disease
onset, which was consistent with former reports [3,4,
13–16]. Furthermore, stricture location, at least in adult-
onset patients, reﬂected initial disease location as described
previously [19,20]. In addition, perianal ﬁstulizing disease
occurred at a similar rate in all age classes (14.7–34.0%)
and at rates comparable with previous reports [4,15].
However, we found that the rates of multiple strictures,
especially small bowel strictures, were signiﬁcantly higher in
paediatric-onset patients, the rate of rectal and anal stric-
tures was the highest in the CD patients with the youngest
age at onset and that the location of strictures was not
correlated with initial disease location as reported previously
in adult-onset patients [19,20]. Second, even though the
need for resectional surgery was much lower in pubertal-
onset patients, colonic surgery was carried out earlier during
the course of disease in the patients with the youngest age at
onset as described by other studies [19–22]. Third, when
looking at PD, we found any type of PD and surgical
intervention to occur signiﬁcantly earlier in CD patients with
the youngest age at onset. In addition, perianal ﬁstulizing
disease was more prevalent among patients with stenosing
or penetrating disease, but not correlated with initial disease
location, as reported in adult patients [13,23,24]. Finally,
anal ﬁssures (47.8 and 34.6%) were signiﬁcantly more
prevalent in paediatric-onset CD, and the rate was much
higher than that reported by a recent study [25].
Table 2. Perianal disease and treatments at any time after diagnosis
Age category [n (%)] (years)
<10 (n=47) <17 (n=182) <40 (n=1000) >40 (n=277) Pa
Total ﬁstulizing PD, patients 16 (34.0)* 42 (23.1) 268 (26.9)* 41 (14.7)* 0.006*
Perianal abscess, patients 8 (50.0) 24 (68.6) 126 (47.0) 20 (48.8) 0.7
Low, high, perianal, perineal or rectovaginal ﬁstula 14 (87.5) 30 (57.1) 223 (83.2) 34 (82.9) 0.3
Anal ﬁssure 11 (23.4)* 19 (10.4) 81 (8.1)* 22 (7.9)* 0.006*
SD and/or PND 7 (77.8) 18 (62.1) 161 (57.9) 23 (54.4) 0.6
Surgical intervention, patients 13 (81.3) 35 (83.3) 200 (74.6) 30 (73.2) 0.6
Surgical intervention and anti-TNF-α 8 (34.8) 14 (26.9) 98 (30.2) 10 (17.2) 0.21
Anti-TNF-α, no surgical intervention 5 (21.7) 11 (21.2) 74 (22.8) 15 (25.9) 0.9
PD, perianal disease; PND, penetrating disease; SD, stricturing disease; TNF-α, tumour necrosis factor-α.
aAfter Bonferroni correction.
*variables with signiﬁcant difference.
Table 3. Association between age at disease onset, initial disease location or having ever been treated with anti-TNFα and outcome in patients with
CD (Multivariate Cox proportional hazard regression)
Small bowel stricture Colonic stricture Abdominal penetrating disease Perianal disease
Outcome RR 95% CI P RR 95% CI P RR 95% CI P RR 95% CI P
Disease onset <17 years 0.62 [0.36–1.18] 0.15 0.37 [0.16–0.86] 0.02 1.16 [0.51–2.64] 0.72 0.55 [0.33–0.91] 0.02
Disease onset <40 years 0.75 [0.42–1.32] 0.32 0.43 [0.22–0.85] 0.02 0.97 [0.45–2.07] 0.94 0.54 [0.35–0.84] 0.01
Disease onset >40 years 0.93 [0.51–1.70] 0.80 0.36 [0.16–0.81] 0.01 0.92 [0.41–2.09] 0.85 0.53 [0.32–0.87] 0.01
L1 1.07 [0.43–2.64] 0.88 NA* 0.73 [0.23–2.34] 0.59 2.72 [0.38–19.75] 0.32
L2 0.17 [0.07–0.44] <0.001 NA* 0.51 [0.16–1.64] 0.26 4.81 [0.67–34.77] 0.12
L3 0.70 [0.29–1.71] 0.43 NA* 0.72 [0.23–2.28] 0.58 4.46 [0.62–32.22] 0.14
Ever treated with anti-TNFα 1.01 [0.86–1.19] 0.91 1.12 [0.91–1.39] 0.29 1.16 [1.01–1.34] 0.04 1.1 [0.97–1.241] 0.12
Age category <10 years and upper GI initial location are treated as base risk, and do not appear.
L1, ileal; L2, colonic; L3, Ileo-colonic.
*Not possible to evaluate: too few cases.
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In summary, in paediatric-onset patients, the higher
rates of strictures and PD and the lack of correlation
between these factors and the initial location of disease
suggest that factors other than the recently reported
genetic determinants of either colonic or ileal disease [26],
may drive inﬂammation, thus resulting in a chronic
inﬂammatory course of disease that is more difﬁcult to
control.
The comparisons of UC patients by groups categorized
according to age at onset yielded the following picture: at
baseline, the overall rate of extensive colitis and the rate of
chronic architectural changes in the initial biopsy were
higher in the paediatric-onset cohort than in the adult-
onset cohort, a difference consistent with the reports of
other groups [16,27–30]. Still, the rate at which patients
with initially left-sided colitis or proctitis were diagnosed
with progression or extension of disease was similar in all
age groups, and the overall total colectomy rate was low,
with no difference observed between age groups as
reported previously by other authors [6,7]. In addition,
backwash ileitis, previously reported to occur in ∼20% of
children and adults [29], was observed with the expected
rate in adult-onset patients. However, progression or
extension of disease occurred more rapidly in patients with
at age at disease onset younger than 17 years, whereas
backwash ileitis occurred with a lower rate and at greater
intervals from diagnosis in paediatric-onset UC and
ﬁnally, the rate of anti-TNF-α antibody treatments was
signiﬁcantly higher in paediatric-onset patients without
colectomy when assessed independent of the initial disease
location.
In summary, the fact that the pancolitis is the most
frequent initial location in paediatric-onset UC may mask
differences in disease behaviour. Only the higher rates of
treatment with biologic agents and the shorter interval
between diagnosis and disease extension point towards the
presence of a more aggressive disease in paediatric UC
patients.
Table 4. Patient characteristics of patients with ulcerative colitis according to age at diagnosis
Age category [n (%)] (years)
<10 (n=42) <17 (n=99) <40 (n=771) >40 (n=289) Pa
Sex (male) (%) 17 (40.5) 47 (47.5) 397 (51.5)* 181 (62.6)* 0.006*
Age at diagnosis [median (IQR)] (months) 84 (62) 161 (33) 328 (131) 615 (167)
Positive family history 5 (11.9) 13 (13.1) 86 (11.2) 23 (8.0) 0.2
NA 0 11 (11.1) 65 (8.5) 32 (11.1)
Initial location
E3 33 (78.6)* 64 (64.7)& 323 (41.9)*,& 104 (36.0)*,& <0.001*,&
E2 5 (11.9)* 16 (16.2)* 258 (33.5)* 115 (39.8)* 0.02
E1 2 (4.7) 14 (14.1) 157 (20.4) 59 (20.4) NS
NA 2 (4.7) 5 (5.1) 65 (8.4) 20 (6.9) 0.7
Histology at diagnostic biopsy
Mucosal secretion depletion 12 (30.0) 23 (25.3) 156 (22.4) 75 (27.9) 0.2
Chronic architectural changes 29 (72.5)* 50 (54.9) 304 (43.7)* 147 (54.6) <0.001*
NA 0 4 (4.4) 91 (13.1) 27 (10.0)
Positive family history 5 (11.9) 13 (13.1) 86 (11.2) 23 (8.0) 0.2
NA 0 11 (11.1) 65 (8.5) 32 (11.1)
Disease duration up to last FU [median (IQR)] (months) 82.5 (143)* 67.5 (149)* 133 (171)* 88 (107) <0.001*
Progression of disease extension
Progression (E1+E2) 2 (28.6) 9 (30.0) 109 (26.3) 34 (19.5) 0.3
Endoscopy after inclusion 7 (16.7)* 19 (19.2) 217 (28.2) 101 (35.0)* 0.02*
Ileal involvement 2 (4.8) 10 (10.1) 141 (18.3) 57 (19.7) NS
Massive haemorrhage 1 (2.4) 4 (4.0) 19 (2.5) 3 (1.0) 0.3
Perforation 0 0 5 (0.7) 3 (1.0) 0.6
Colonic resection 4 (9.5) 4 (4.0) 92 (11.9) 30 (10.4) 0.1
Total colectomy 3 (7.1) 3 (3.0) 67 (8.7) 14 (4.8) NS
Anti-TNF-α
No surgery 13/38 (34.2)* 16/95 (16.8)& 86/679 (12.7)* 19/259 (7.3)*,& 0.05
Plus surgery 0 0 23 4
E1, ulcerative proctitis; E2, left-sided UC; E3, extensive colitis; FU, follow-up; IQR, interquartile range TNF-α, tumour necrosis factor-α.
aBonferroni corrected differences.
*,&Variables causing the difference.
Table 5. Association between age at disease onset, initial disease location and outcome in patients with ulcerative colitis (multivariate cox proportional
hazard regression)
Total colectomy (UC only) Disease progression (UC only) Backwash ileitis
Outcomes RR 95% CI P value RR 95% CI P value RR 95% CI P value
Age category (<17 years) 0.52 0.10–2.60 0.4 1.91 0.41–8.91 0.41 2.37 0.52–10.85 0.27
Age category (<40 years) 0.73 0.23–2.40 0.6 0.82 0.20–3.40 0.79 2.19 0.54–8.91 0.28
Age category (>40 years) 0.85 0.29–3.5 0.8 1.28 0.30–5.45 0.47 4.36 1.05–18.05 0.04
Initial location E2 0.54 0.33–0.91 0.02 1.47 1.0–2.15 0.05 0.62 0.45–0.85 0.003
Initial location E1 0.34 0.16–0.71 0.004 1.48 0.93–2.36 0.10 0.53 0.36–0.79 0.002
Ever treated with anti-TNF-α 2.47 1.48–4.11 0.001 1.32 0.83–2.1 0.24 1.94 1.36–2.75 <0.001
Age category <10 years and pancolonic initial location are treated as base risk and do not appear.
CI, conﬁdence interval; E1, ulcerative proctitis; E2, left-sided UC; TNF-α, tumour necrosis factor-α; UC, ulcerative colitis.
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The present study has several limitations. First, this
study is not population based. In Switzerland, many adult
IBD patients are followed by gastroenterologists in private
practice, particularly patients with uncomplicated diseases
living in regions without easy access to university hospi-
tals. Second, the patient data for disease evolution and
treatment choices before study inclusion were not available
and the performance of comparisons of these variables
between age groups was not possible. Third, data on the
pubertal stages of patients with early-onset IBD were not
available, and some patients may have been mis-
categorized according to age because of delayed puberty.
Fourth, the disease duration was the longest in patients
diagnosed at more than 40 years of age, which was likely
one reason why a higher rate of complications was found
in this age group. Finally, our paediatric groups were small
in size, and the question of whether complications are
correlated with genetic predisposition, as seems to be the
case in adult-onset disease, should be answered by looking
at larger cohorts. Nevertheless, we showed that paediatric-
onset IBD was associated with the most signiﬁcant burden
of intestinal complications, and we are the ﬁrst to present a
comparative overview of these complications.
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